Catalent Biologics Analytical Services: Outsourced Pharma Capabilities Update March 2026
Abstract: Catalent’s biologics analytical services are designed to deliver comprehensive support for a diverse range of biologic modalities, including antibodies, conjugates, peptides, nucleic acids, and cell and gene therapies. From discovery and early-stage developability, formulation and method development to late-stage validation, characterization, quality control and commercial support, Catalent’s analytical capabilities span across the full drug development lifecycle. In this presentation, Luke Dieters, Head of Biologics Analytical Services at Catalent, highlights how the company’s patient-first approach, technical excellence and strong regulatory compliance, combined with its ability to provide both stand-alone and integrated solutions for method development, characterization, stability studies and bioassays, has led to high client satisfaction driven by scientific expertise and dedicated project teams.